Form 4: Bio-Rad Laboratories COO Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Jonathan P. Divincenzo, President & COO of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on September 4, 2026.

Summary

  • Option exercise/conversion: acquired 1,712 Bio-Rad A Common Stock on September 5, 2026; holds 2,631 after (Direct).
  • Tax/exercise-price withholding: disposed of 668 Bio-Rad A Common Stock at $386.11 ($257,921) on September 5, 2026; holds 1,963 after (Direct).
  • Grant/award: acquired 6,326 Restricted Stock Units on September 4, 2026; holds 6,326 after (Direct).
  • Option exercise/conversion: disposed of 1,712 Restricted Stock Units on September 5, 2026; holds 5,138 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Jonathan P. Divincenzo — Officer (President & COO)

DateTransactionSecuritySharesPriceValueHeld After
2026-09-05Option exercise/conversionBio-Rad A Common Stock1,712——2,631
2026-09-05Tax/exercise-price withholdingBio-Rad A Common Stock668$386$257.9K1,963
2026-09-04Grant/awardRestricted Stock Units6,326——6,326
2026-09-05Option exercise/conversionRestricted Stock Units1,712——5,138

Key Dates

DateDescription
2026-09-05Option exercise/conversion (1,712 shares)
2026-09-05Tax/exercise-price withholding (668 shares)
2026-09-04Grant/award (6,326 shares)
2026-09-05Option exercise/conversion (1,712 shares)

Keywords

insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Jonathan P. Divincenzo

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.